Pancreatic Cancer

There are two forms of pancreatic cancer, exocrine pancreatic cancer, which accounts for approximately 95 percent of all cases, and endocrine or pancreatic neuroendocrine tumors, also called islet cell tumors. Pancreatic cancer often has a poor prognosis and is projected to become the second leading cause of cancer death in the United States behind lung cancer by 2030. 

The pancreas has two main jobs in the body, making the juices that help with digestion and making hormones such as insulin and glucagon that help control blood sugar levels. Smoking and health history including being overweight, having diabetes, chronic pancreatitis, and certain hereditary conditions are risk factors for pancreatic cancer.

The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program estimated that there will be 56,770 people diagnosed with pancreatic cancer in the United States and some 45,750 deaths from these cancers in 2019.

The five year survival rate for pancreatic cancer is just 9.3 percent.

Source: National Cancer Institute​


The AACR - Impacting Cancer Research and Care

Targeting Tumors' Blood Supply

Cancer researcher Renata Pasqualini, PhD, takes aim at cancer with novel approaches to developing targeted diagnostic, imaging, and therapeutic strategies.  Read More.

Aspirin May Reduce Risk for Pancreatic Cancer

In a new study, researchers found that regular use of aspirin reduced pancreatic cancer risk by almost 50 percent.  Read More.

The American Association for Cancer Research (AACR) is a 501c3 registered nonprofit organization with offices at 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106 | 215.440.9300